> top > docs > PubMed:32842509 > annotations

PubMed:32842509 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T1 31-39 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T2 100-108 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T3 309-317 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T4 353-361 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T5 568-576 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T6 839-847 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T1 70-71 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T2 180-181 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T3 916-923 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T1 223-228 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T2 331-335 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T3 431-435 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T4 584-603 Chemical denotes protease inhibitors http://purl.obolibrary.org/obo/CHEBI_37670|http://purl.obolibrary.org/obo/CHEBI_60258
T6 593-603 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T7 664-673 Chemical denotes molecules http://purl.obolibrary.org/obo/CHEBI_25367
T8 791-795 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T9 820-825 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T10 855-874 Chemical denotes protease inhibitors http://purl.obolibrary.org/obo/CHEBI_37670|http://purl.obolibrary.org/obo/CHEBI_60258
T12 864-874 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T1 395-412 http://purl.obolibrary.org/obo/GO_0019079 denotes viral replication
T2 395-412 http://purl.obolibrary.org/obo/GO_0019058 denotes viral replication

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
1 31-41 Species denotes SARS-CoV-2 Tax:2697049
7 100-110 Species denotes SARS-CoV-2 Tax:2697049
8 309-317 Disease denotes COVID-19 MESH:C000657245
9 353-363 Species denotes SARS-CoV-2 Tax:2697049
10 568-578 Species denotes SARS-CoV-2 Tax:2697049
11 839-849 Species denotes SARS-CoV-2 Tax:2697049

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T1 0-95 Sentence denotes Drug Repurposing for Candidate SARS-CoV-2 Main Protease Inhibitors by a Novel In Silico Method.
T2 96-250 Sentence denotes The SARS-CoV-2 outbreak caused an unprecedented global public health threat, having a high transmission rate with currently no drugs or vaccines approved.
T3 251-348 Sentence denotes An alternative powerful additional approach to counteract COVID-19 is in silico drug repurposing.
T4 349-443 Sentence denotes The SARS-CoV-2 main protease is essential for viral replication and an attractive drug target.
T5 444-604 Sentence denotes In this study, we used the virtual screening protocol with both long-range and short-range interactions to select candidate SARS-CoV-2 main protease inhibitors.
T6 605-761 Sentence denotes First, the Informational spectrum method applied for small molecules was used for searching the Drugbank database and further followed by molecular docking.
T7 762-924 Sentence denotes After in silico screening of drug space, we identified 57 drugs as potential SARS-CoV-2 main protease inhibitors that we propose for further experimental testing.